Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
67,309,218
-
Share change
-
+7,432,774
-
Total reported value
-
$7,537,073,926
-
Put/Call ratio
-
128%
-
Price per share
-
$111.96
-
Number of holders
-
683
-
Value change
-
+$817,030,247
-
Number of buys
-
287
-
Number of sells
-
257
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2021
As of 31 Dec 2021,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
683 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,309,218 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, BANK OF AMERICA CORP /DE/, CITIGROUP INC, TORONTO DOMINION BANK, MORGAN STANLEY, UBS Group AG, JANE STREET GROUP, LLC, BOXER CAPITAL, LLC, and BARCLAYS PLC.
This page lists
687
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.